NEW YORK (AP) - A panel of vaccine experts will meet in early November to consider whether to recommend the Pfizer COVID-19 vaccine for children younger than 12.The Advisory Committee of Immunization Practices scheduled a two-day meeting for Nov.
2-3, health officials said Friday. The Pfizer topic is expected to take up part of the agenda.RELATED: Pfizer seeks FDA authorization of COVID-19 vaccine for kids 5 to 11The experts are anticipating the U.S.
Food and Drug Administration will have decided by then whether to authorize use of the Pfizer vaccine for children between ages 5 to 11.
The committee’s job is to help the U.S. Centers for Disease Control and Prevention develop recommendations for doctors and the public about which vaccines.